1,3-beta-D-glucan in patients receiving intravenous amoxicillin-clavulanic acid.
Mennink-Kersten
Monique A S H
MA
Warris
Adilia
A
Verweij
Paul E
PE
D019980:Amoxicillin-Potassium Clavulanate Combination / Q000737:chemistry / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000627:therapeutic use*; D003429:Cross Reactions; D005189:False Positive Reactions; D006801:Humans; D007275:Injections, Intravenous; D009181:Mycoses / Q000175:diagnosis; D011509:Proteoglycans; D047071:beta-Glucans / Q000097:blood* / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D011509:Proteoglycans; D047071:beta-Glucans; C010770:polysaccharide-K; D019980:Amoxicillin-Potassium Clavulanate Combination